| Lower urinary tract dysfunction in MS: management in the community. | |
| | |
MedLine Citation:
|
PMID: 20166471 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Lower urinary tract dysfunction in multiple sclerosis is common and is highly amenable to treatment. Individuals may have bladder storage and/or voiding dysfunction. The risk of progression to renal failure is low and hence lower urinary tract dysfunction should be considered medically manageable in most individuals. Evaluation begins with history taking and is supplemented by using a bladder diary. Ultrasonography is used to assess the degree of incomplete bladder emptying, and for assessing upper urinary tract damage. Incomplete bladder emptying is most often managed by clean intermittent self-catheterization and should be initiated if post-void residual urine is greater than 100 mls. Storage symptoms are most often managed using antimuscarinic medications. Other options include desmopressin or detrusor muscle injection of botulinum toxin type A. There are specific situations where specialist urology services should be involved. |
| | |
Authors:
|
Jalesh Panicker; Collette Haslam |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: British journal of community nursing Volume: 14 ISSN: 1462-4753 ISO Abbreviation: Br J Community Nurs Publication Date: 2009 Nov |
Date Detail:
|
Created Date: 2010-02-19 Completed Date: 2010-03-05 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9815827 Medline TA: Br J Community Nurs Country: England |
Other Details:
|
Languages: eng Pagination: 474, 476, 478-80 Citation Subset: N |
Affiliation:
|
Department of Uro-Neurology, National Hospital for Neurology and Neurosurgery, London. j.panicker@ion.ucl.ac.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Algorithms Antidiuretic Agents / therapeutic use Botulinum Toxin Type A / therapeutic use Community Health Nursing / methods* Deamino Arginine Vasopressin / therapeutic use Humans Multiple Sclerosis / complications* Muscarinic Antagonists / therapeutic use Neuromuscular Agents / therapeutic use Nursing Assessment Referral and Consultation Risk Factors Self Care Urinary Bladder, Overactive / prevention & control Urinary Catheterization Urinary Tract Infections / prevention & control Urination Disorders / diagnosis, etiology, prevention & control* Urodynamics |
| Chemical | |
Reg. No./Substance:
|
0/Antidiuretic Agents; 0/Botulinum Toxin Type A; 0/Muscarinic Antagonists; 0/Neuromuscular Agents; 16679-58-6/Deamino Arginine Vasopressin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Overactive bladder syndrome in the older woman: conservative treatment.
Next Document: Mentoring a student immediately prior to registration: a qualitative study.